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Posthemorrhagic hydrocephalus of prematurity (PHHP) remains a global challenge. Early
preterm infants (<32 weeks gestation), particularly those exposed to chorioamnionitis
(CAM), are prone to intraventricular hemorrhage (IVH) and PHHP. We established
an age-appropriate, preclinical model of PHHP with progressive macrocephaly and
ventriculomegaly to test whether non-surgical neonatal treatment could modulate
PHHP. We combined prenatal CAM and postnatal day 1 (P1, equivalent to 30 weeks
human gestation) IVH in rats, and administered systemic erythropoietin (EPO) plus
melatonin (MLT), or vehicle, from P2 to P10. CAM-IVH rats developed progressive
macrocephaly through P21. Macrocephaly was accompanied by ventriculomegaly at
P5 (histology), and P21 (ex vivo MRI). CAM-IVH rats showed impaired performance
of cliff aversion, a neonatal neurodevelopmental test. Neonatal EPO+MLT treatment
prevented macrocephaly and cliff aversion impairment, and significantly reduced
ventriculomegaly. EPO+MLT treatment prevented matted or missing ependymal motile
cilia observed in vehicle-treated CAM-IVH rats. EPO+MLT treatment also normalized
ependymal yes-associated protein (YAP) mRNA levels, and reduced ependymal
GFAP-immunolabeling. Vehicle-treated CAM-IVH rats exhibited loss of microstructural
integrity on diffusion tensor imaging, which was normalized in EPO+MLT-treated
CAM-IVH rats. In summary, combined prenatal systemic inflammation plus early
postnatal IVH caused progressive macrocephaly, ventriculomegaly and delayed
development of cliff aversion reminiscent of PHHP. Neonatal systemic EPO+MLT
treatment prevented multiple hallmarks of PHHP, consistent with a clinically viable,
non-surgical treatment strategy.
Keywords: intraventricular hemorrhage (IVH), chorioamnionitis, neurorepair, ventriculomegaly, diffusion tensor
imaging (DTI), preterm, cilia, cerebrospinal fluid
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maturation of neural cells (Iwai et al., 2010; Mazur et al., 2010;
Jantzie et al., 2013; Li et al., 2017; Zhang et al., 2018), reduce
excess calpain degradation (Samantaray et al., 2008; Jantzie et al.,
2014b, 2016; Robinson et al., 2016), limit neuroinflammation
and oxidative damage (Carloni et al., 2016; Ramirez-Jirano
et al., 2016; Dominguez Rubio et al., 2017; McDougall et al.,
2017; Wang et al., 2017; Wei et al., 2017; Zhou et al., 2017),
and suppress endoplasmic reticulum stress and mitochondrial
dysfunction (Hong et al., 2012; Das et al., 2013; Carloni et al.,
2014; Fernandez et al., 2015; Hadj Ayed Tka et al., 2015; Zhao
et al., 2015; Hu et al., 2016; Hardeland, 2017; Mendivil-Perez
et al., 2017; Tang et al., 2017; Xue et al., 2017). Individually, EPO
and MLT are in clinical trials to ameliorate CNS injury from
extremely preterm birth, demonstrating their clinical viability
as therapeutics in preterm infants (Juul et al., 2008; Ohls et al.,
2014, 2016; Fauchere et al., 2015; Wu et al., 2016; Carloni et al.,
2017). A multi-pronged therapeutic approach is commonly used
for other medical disorders that have multiple interacting targets,
and may benefit PHHP (Gonzalez and Ferriero, 2008).
The association of intrauterine inflammation, or
chorioamnionitis (CAM), with IVH has been recognized
around the world (Moscuzza et al., 2011; Salas et al., 2013;
Arayici et al., 2014; Shankaran et al., 2014; Lee et al., 2016; Lu
et al., 2016; Stark et al., 2016; Chevallier et al., 2017; Edwards
et al., 2018). In a recent study, 26.7% of early preterm infants
with CAM exposure suffered IVH, compared to only 17.8%
of infants without CAM exposure (Edwards et al., 2018).
Systemic inflammation is also implicated in the need for surgical
intervention for PHHP (Alan et al., 2012). In a longitudinal
study of early preterm infants, the incidence of IVH remained
stable at 8% for over a decade (Alan et al., 2012). By contrast,
the incidence of sepsis dropped significantly. Interestingly,
the need for surgical intervention for PHHP declined and
followed the sepsis trend, rather than remaining stable and
trending with IVH (Alan et al., 2012). Decades ago, Rypens
et al. (1994) described widespread ependymal changes after IVH
visualized throughout the ventricular system on HUS. These
changes were not restricted to areas of IVH, implicating a diffuse
ependymal reaction after IVH. Together, these clinical studies
suggest associations between prenatal systemic inflammation
that impacts the developing CNS, an increased risk of IVH,
diffuse ependymal reaction following IVH, and the greater need
for surgical intervention to treat symptomatic hydrocephalus.
Recent advances in neuroscience have shed new insights
on the pathogenesis of symptomatic hydrocephalus. Ependymal
motile cilia (EMC) propel CSF through the ventricles (Banizs
et al., 2005; Sawamoto et al., 2006; Faubel et al., 2016). Ependymal
cells arise from radial glia in the third trimester (Spassky et al.,
2005), which in rodents is equivalent to approximately the first
postnatal week (Semple et al., 2013; Jantzie and Robinson, 2015).
The genesis, maturation and anatomical arrangement of EMC
is complex and strictly regulated during development, primarily
from postnatal day 3 (P3) through 21 in rats (Banizs et al., 2005;
Guirao et al., 2010; Mirzadeh et al., 2010; Tissir et al., 2010; Lattke
et al., 2012; Delgehyr et al., 2015; Kyrousi et al., 2015; Feldner
et al., 2017; Takagishi et al., 2017; Abdelhamed et al., 2018; Cho
et al., 2018; Mahuzier et al., 2018). Development of EMC occurs

INTRODUCTION
Posthemorrhagic hydrocephalus of prematurity (PHHP) is a
severe form of acquired symptomatic hydrocephalus. PHHP,
the combination of ventriculomegaly and elevated intracranial
pressure, occurs most commonly in preterm infants who
suffer severe intraventricular hemorrhage (IVH) during the
first few days of life. Severe IVH is defined as germinal
matrix hemorrhage distending a ventricle or involving adjacent
parenchyma. Worldwide, ∼1.6 million early preterm infants
(<32 weeks gestation) are born annually (Blencowe et al., 2012).
In countries with advanced medical care, 8–23% of these early
preterm infants (∼300,000 infants per year) are afflicted by
severe IVH (Alan et al., 2012; Radic et al., 2015; Romero et al.,
2015; Poryo et al., 2017). Symptomatic PHHP typically develops
weeks after IVH, and represents the worst outcome along a
spectrum of severity after severe IVH. The spectrum ranges from
ventriculomegaly without signs of elevated intracranial pressure
to symptomatic PHHP that requires an invasive intervention.
Of surviving early preterm infants with severe IVH, 50–60%
will exhibit ventriculomegaly on head ultrasound (HUS) during
the newborn admission (Alan et al., 2012; Romero et al., 2015),
20–30% will develop symptomatic hydrocephalus that requires
temporary treatment (Alan et al., 2012; Radic et al., 2015), and
16–20% will require permanent intervention (Alan et al., 2012;
Radic et al., 2015; Romero et al., 2015). Currently, the only
effective treatment for PHHP is surgical intervention (Mazzola
et al., 2014), yet most infants and children throughout the
world do not have access to safe, timely neurosurgical care
(Muir et al., 2016). In the United States, pediatric hydrocephalus
treatment consumes $1.4–2 billion dollars annually (2003
dollars) (Simon et al., 2008). The most common neurosurgical
intervention for PHHP, insertion of a permanent cerebrospinal
fluid (CSF) shunt, brings lifelong dependence on devices prone
to malfunction and infection. In a recent multi-center study
in the United States, PHHP was the most common reason for
initial shunt insertion, and one third of initial infant shunts
failed with a mean time to failure of <1 year (Riva-Cambrin
et al., 2016). Shunt outcomes are much worse in regions without
advanced neurosurgical care (Santos et al., 2017). Other surgical
options for infants, such as endoscopic third ventriculostomy
with choroid plexus coagulation (ETV-CPC), have not shown
superior durability to shunts (Kulkarni et al., 2018). The need
for safe, effective, economical, non-surgical treatment of PHHP
cannot be over-stated.
Over the past two decades, perinatal neuroreparative strategies
have been translated into clinical trials (Johnston et al., 2011;
Leuchter et al., 2014; Ohls et al., 2014; Wu et al., 2016; Juul
et al., 2018) and practice (Gluckman et al., 2005). This progress
motivated us to re-examine non-surgical treatment of PHHP.
The pluripotent cytokines, erythropoietin (EPO) and melatonin
(MLT), are leading candidates for neurorepair in neonates with
central nervous system (CNS) injury due to their safety profile
(Robertson et al., 2012), and multiple and complementary,
mechanisms of action on developing neural cells (Brines et al.,
2000; Carloni et al., 2008; Mazur et al., 2010; Jantzie et al.,
2018). Both EPO and MLT support the genesis, survival and
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assays. No animals were individually excluded except, as noted
in the text, those who were removed prior to P21 due to poor
health. DTI images from one rat were excluded due to poor
image acquisition quality prior to quantification. Rats from
both institutions and at least two separate litters were used
for all experiments, except rats for SEM were prepared at one
institution. Rats from both sexes were randomly assigned to
injury (CAM versus sham at E18, IVH versus vehicle at P1)
and to treatment group (EPO+MLT or vehicle on P2 for CAMIVH rats). Each rat pup was coded to ensure all observations
and assays and data analyses were performed blinded prior to
decoding for interpretation.

precisely during the perinatal period when early preterm infants
suffer associated CNS injury from CAM and IVH (Delgehyr
et al., 2015). After IVH in human preterm infants, ependymal
cells lining the ventricles are replaced by astrocytic glial nodules
in a process termed ventricular disruption (Fukumizu et al.,
1995, 1996; McAllister et al., 2017). Similarly, EMC injury occurs
following intracerebral hematoma (Chen et al., 2015), traumatic
brain injury (TBI) (Xiong et al., 2014) and stroke (Young et al.,
2013). Converging lines of evidence suggest that damage to EMC
leads to excessive accumulation of CSF and symptoms of elevated
intracranial pressure.
We propose EMC failure leading to symptomatic
hydrocephalus is precipitated by systemic inflammation in
combination with a second CNS insult, such as hemorrhage or
TBI. Yung et al. (2011) demonstrated that fetal intraventricular
lysophosphatidic acid (LPA), a blood-borne inflammatory
signaling molecule, precipitates congenital hydrocephalus, and
Park subsequently showed that LPA reduces yes-associated
protein (YAP), and ependymal maturation (Park et al., 2016).
YAP drives the differentiation of radial glial cells toward
ependymal cells (Park et al., 2016). Without adequate YAP
present, radial glial cells become astrocytes (Huang et al., 2016).
We hypothesize that CAM plus early IVH induces symptomatic
hydrocephalus that replicates human infant PHHP, and that
this occurs in part through alteration of periventricular YAP.
Moreover, we propose that combined treatment with EPO and
MLT can prevent EMC damage, and thus PHHP. Herein, we
report a novel, clinically relevant model of PHHP that combines
prenatal injury to induce CNS inflammation plus early postnatal
IVH, and prevention of PHHP with neonatal EPO+MLT
treatment. This clinically viable, non-surgical intervention
prevents acquired hydrocephalus in a preclinical model that
exhibits macrocephaly, ventriculomegaly and developmental
delay (poor cliff aversion performance), mimicking symptomatic
PHHP in human infants.

Animals
All procedures followed the National Research Council
guidelines, and were performed with the approval of IACUCs at
Johns Hopkins University (RA16M369) and the University of
New Mexico Health Sciences Center (16-200398-HSC). Timed
pregnant Sprague-Dawley dams were purchased (Charles River).
Rats had ad libitum food and water, and a standard 12-h light
dark cycle. Pups were raised with dams and weaned at P21.
Pups were monitored daily for weight and other signs of health.
A total of 298 pups were used for this study. Both sexes, and rats
from at least two separate litters were used for all experiments.
The experimental paradigm is presented in Figure 1A. ARRIVE
guidelines were followed (Kilkenny et al., 2010). An initial cohort
of 135 rat pups [43 sham-vehicle (sterile saline), 35 sham-IVH,
27 CAM-vehicle, and 30 CAM-IVH] was used to establish the
model of PHHP. A second cohort of 89 rats (31 sham-veh
rats, 35 CAM-IVH vehicle-treated rats, and 23 CAM-IVH
EPO+MLT-treated rats) was used to test if treatment begun on
P2 could prevent the development of PHHP. A third cohort of 74
pups (10 naïve vehicle-treated rats, 20 naïve EPO+MLT-treated
rats, 13 vehicle-treated CAM-vehicle rats, 8 vehicle-treated
CAM-IVH rats, 5 MLT-treated CAM-IVH rats, 9 EPO-treated
CAM-IVH rats, and 9 EPO+MLT-treated CAM-IVH rats) was
used for additional control experiments. Whenever possible,
each pup was used for multiple assays.

MATERIALS AND METHODS
Study Design

Chorioamnionitis (CAM) on Embryonic
Day 18

The primary study objective was to determine if progressive
macrocephaly and ventriculomegaly could be reliably induced
in neonatal rats using a combination of CAM and IVH,
and if combinatorial therapy with EPO+MLT could prevent
these two hallmarks of PHHP. For each experiment with a
statistical analysis, a power analysis was performed to estimate
the required sample size (G∗ Power 3.1.9.3). We used preliminary
and published data to estimate means and standard deviations
for each group for the primary outcomes of intra-aural distance,
ventriculomegaly, neurodevelopmental assessment, qPCR, and
DTI analyses (Farkas et al., 2009; Yung et al., 2011; Baharnoori
et al., 2012; Jantzie et al., 2014a,b, 2018; Robinson et al., 2016).
Scanning electron microscopy qualitative analysis of EMC was
set a priori as two per group. Primary endpoints were set a
priori as described in the text, and were daily (P4-P15 and
P21) for IAD and neurodevelopment, P5 for ventriculomegaly,
P15 for periventricular YAP mRNA, and P21 for remaining
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To induce CAM, under isoflurane anesthesia pregnant dams
underwent laparotomy on embryonic day 18 (E18) with transient
uterine artery occlusion for 60 min followed by intra-amniotic
injection of lipopolysaccharide (LPS, 0111:B4, Sigma, St. Louis,
MO, United States, 4 µl/sac) (Jantzie et al., 2014a, 2015b;
Maxwell et al., 2015). The laparotomy was closed and pups were
born on E22. Shams underwent anesthesia and laparotomy for
60 min without uterine artery occlusion or LPS injection. 44
dams underwent laparotomy to generate the animals for this
study.

Intraventricular Injection on Postnatal
Day 1
For litters with IVH injection, one pup from each litter was
randomly chosen as a donor for syngeneic lysed red blood cells
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FIGURE 1 | Prenatal chorioamnionitis (CAM) plus postnatal day 1 (P1) intraventricular injection of lysed red blood cells (IVH), or CAM-IVH, causes progressive
macrocephaly, ventriculomegaly and neurodevelopmental delay. (A) Experimental paradigm. (B) Coronal head ultrasound on P2 demonstrating bilateral IVH.
(C) A representative P7 rat with CAM-IVH exhibits a domed cranial vault, while a sham-IVH rat does not. (D) CAM-IVH rats show a disproportionate increase in
intra-aural distance (IAD), a surrogate for head circumference, while control rats (sham-veh, sham-IVH and CAM-veh) do not. (E) Hematoxylin and eosin staining of
coronal sections of the lateral ventricle at P5 demonstrate ventriculomegaly in CAM-IVH rats. Bar = 500 microns. (F) Ventricular volume measured with unbiased
stereology of HE sections at P5 is mildly increased in CAM-veh rats, and markedly elevated in CAM-IVH rats, compared to sham-veh or sham-IVH rats. (G)
Ventricular volume quantified from coronal ex vivo T2 MRI slices shows that ventriculomegaly in CAM-IVH rats is sustained through P21, compared to sham-veh,
sham-IVH and CAM-veh rats. (H) Both CAM-veh and CAM-IVH rats exhibit delayed performance on cliff aversion, a neonatal neurodevelopmental test. (D is mixed
model repeated measures ANOVA with Bonferroni’s correction and all other comparisons are two-way ANOVA with Bonferroni’s correction, ∗ p < 0.05, ∗∗ p ≤ 0.01,
∗∗∗ p ≤ 0.001.)

Extend Dual Probe, GE Healthcare) was used to confirm IVH
on P2.

(RBCs). Lysed RBCs were chosen because of prior work that
suggested lysed RBCs best replicate human IVH (Strahle et al.,
2012; Gao et al., 2014). Donor blood was collected, centrifuged
at 500 × g for 10 min, washed three times with sterile PBS
(phosphate-buffered saline), and then lysed with a standardized
series of freeze-thaw cycles. On postnatal day 1 (P1), CAM or
sham pups were randomly assigned to injection of lysed RBCs
(IVH) or vehicle (sterile saline, pH 7.4). The mean hematocrit
of P1 lysed RBCs was 37.2 ± 0.9% for shams (n = 3) and
36.9 ± 0.6% for CAM rats (n = 3). Using hypothermia for
sedation, transillumination, and standard landmarks for the
lateral ventricle (0.2 mm anterior to the coronal suture and
1 mm lateral of midline), either vehicle or lysed RBCs (20 µl)
was injected into each lateral ventricle using a micro-syringe
with a 31 gauge needle (Kim et al., 2014; Mukai et al., 2017).
Lysed RBCs or vehicle was slowly infused freehand with a
percutaneous needle, as previously reported, because neonatal
rats at P1 cannot be placed in a stereotactic frame (Mukai et al.,
2017). Placement was confirmed visually with transillumination.
After 15–20 s the needle was removed, and pups were rewarmed
and returned to their dams. Rats were coded and labeled to
blind observers for subsequent assessments. Ultrasound (VScan
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Extended Erythropoietin (EPO) Plus
Melatonin (MLT) Treatment
To test if EPO+MLT could prevent the onset of PHHP, on P2
CAM+IVH rats were randomized to receive either EPO+MLT
or vehicle from P2 (equivalent to approximately 32 weeks
human gestation) to P10 (full term in humans). Six doses
of EPO (2500 U/kg/dose i.p.) or vehicle were administered
on P2-P5, P7 and P9. Nine doses of MLT (20 mg/kg/dose
i.p.) or vehicle were administered on P2-P10. A subset of
36 CAM-IVH pups were randomized to receive vehicle, EPO
alone, MLT alone, or EPO+MLT to test impact of treatment
on macrocephaly. Shams did not receive EPO+MLT because
both EPO and MLT have previously been shown to be safe
in these dosing regimens as individual agents (Juul et al.,
2008; Mazur et al., 2010; Ohls et al., 2014; Fauchere et al.,
2015; Carloni et al., 2017). To determine if EPO+MLT had
any unanticipated effect on normal neurodevelopment, a set
of naïve pups underwent EPO+MLT treatment. Doses were
administered the same time of day to minimize any impact
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Following extraction, RNA was transcribed to cDNA, followed
by RT-PCR using SYBR green and YAP primers. Experimental
replicates were run in triplicate and those CT values varying
by more than 0.25 standard deviations were excluded from all
analyses. Pooled adult naïve cortex was used to standardize across
plates.

of MLT on the circadian rhythm, although no impact was
evident.

Intra-Aural Distance (IAD)
Observers blinded to injury and treatment group measured 200
rats (cohort 1 = 87, cohort 2 = 69, and cohort 3 = 44). Daily
measurements included IAD (Yung et al., 2011) and body weight
for dosing calculations.

MRI for Ventricular Volume and
Microstructural Integrity

Neurodevelopmental Assessment

Ex vivo MRI T2 and diffusion tensor imaging (DTI) images were
acquired at P21 on 33 rats using a Bruker Biospec 7T 70/30
Ultra Shield Refrigerated (USR) nuclear MRI system. Briefly, rats
were anesthetized and perfused with PBS, followed by 4% PFA.
Brains were post-fixed in 4% PFA for 1 week and embedded in
2% agarose containing 3 mM sodium azide. A T2 multi-slice
multi-echo (MSME) sequence was performed with a TR of
3000 ms and TE of 12 ms. FOV was 3 cm × 3 cm, with a slice
thickness of 1 mm, 12 slices total, and matrix of 256 × 256, as
previously published (Jantzie et al., 2015a; Robinson et al., 2016).
Echo-planar diffusion tensor imaging (EP-DTI) images of twelve
contiguous coronal 1 mm slices was obtained with a FOV of 3.
Ventricular volume was calculated from manually traced regions
of interest (ROI) by observers blinded to injury and treatment
status. Areas within each slice were calculated, summed across
slices and multiplied by slice thickness. DTI was quantified for
ROI consistent with previous publications (Jantzie et al., 2015a;
Robinson et al., 2016). Because the intraventricular injections
were performed bilaterally, for bilateral structures the metrics
were acquired on each side and averaged per ROI for each rat.

Neurodevelopmental battery included nine tests (surface
righting, negative geotaxis, cliff aversion, forelimb grasp, audio
startle, eye opening, ear twitch, forelimb placement, and air
righting) (Farkas et al., 2009; Baharnoori et al., 2012). Since
no differences with audio startle or eye opening were noted
across groups, these two tests were not included for naïve rats.
Observers blinded to injury and treatment group tested 146 rats
each day from P4 to P15, and then at P21.

Histology
Animals were anesthetized and perfused with PBS and then
4% paraformaldehyde (PFA), and brains were collected. After
immersion in 30% sucrose, coronal frozen sections were
cut on a cryostat. Hematoxylin and eosin (HE) staining,
immunohistochemistry (IHC) and unbiased stereology were
performed, as previously published (Jantzie et al., 2014a).
Sections stained with HE were used for ventricular volume.
For IHC, briefly, sections were washed and then incubated
sequentially with 0.3% hydrogen peroxide and blocking solution
containing 10% goat serum in PBS. Primary GFAP antibodies
(Dako 1:500, Carpinteria, CA, United States) in blocking solution
containing 0.1% Triton were incubated on sections overnight at
4◦ C. The next morning, sections were rinsed, incubated with
species-appropriate biotinylated secondary antibodies, followed
by Vectastain (Vector Labs, Burlingame, CA, United States) and
30 30 -diaminobenzidine (DAB). Sections were dehydrated, cleared
in xylenes and cover-slipped with Permount (Millipore Sigma,
St. Louis, MO, United States). Although dehydration can affect
ventricular volume measurements in slide mounted sections,
all sections were dehydrated equally, including equivalent
times in graded ethanol solutions and xylenes. Appropriate
negative controls (no primary antibodies) were run in parallel.
Using bright-field illumination, representative images were
photographed on a Leica microscope. Observers blinded to
injury and treatment status quantified ventricular volumes with
Stereologer software (Stereology Resource Center, Tampa, FL,
United States) on an upright Leica microscope using optical
fractionator methodology under the 40× objective.

Scanning Electron Microscopy (SEM)
Six rats on P21 were perfused with PBS, followed by a mixture
of 2.5% glutaraldehyde/2% PFA/0.1 M sodium cacodylate/HCl
buffer pH 7.2. Anterior and posterior areas of the lateral or
medial walls of the lateral ventricles were micro-dissected and
fixed overnight. Anatomically matched tissues were incubated in
1% osmium tetroxide in 0.1 sodium cacodylate/HCl buffer for 4 h,
dehydrated in a series of graded ethanol solutions, carbon-coated,
then imaged in a Zeiss Sigma 300 field emission scanning electron
microscope, consistent with published reports (Sawamoto et al.,
2006; Xiong et al., 2014).

Quantification and Statistical Analysis
In all studies, each rat represents true n. Observers were blinded
to injury and treatment status for all data acquisition and initial
analyses. For all data sets normal distribution was verified with
the Shapiro–Wilk test, with Levene’s test to confirm homogeneity
of variances. For comparisons of multiple groups that were
normal in distribution, two-way ANOVA with Bonferroni’s
correction was performed (SPSS 24, IBM). For comparison of
IADs across groups and ages, a mixed model repeated measures
ANOVA with Bonferroni correction was used. For comparison
of non-parametric values (categories of ventricular volume),
Wilcoxon rank sum test was performed. A Type I error of
p < 0.05 was considered significant. Mean diffusivity ellipsoids
were graphed with MATLAB, R2017b.

Quantitative PCR
Quantitative PCR was performed as previously published (Jantzie
et al., 2014a). Primers for YAP were obtained from the literature
(Huang et al., 2016), and verified with BLAST (National Center
for Biotechnology Information Nucleotide Basic Local Alignment
Search Tool). Briefly, ependyma at P15 were rapidly dissected
for RNA isolation (RNeasy Mini kit; Qiagen, Germantown).
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IAD measurements and ventricular volumes from histology and
MRI demonstrate that only the combination of prenatal CAM
plus early postnatal IVH leads to progressive macrocephaly with
persistent ventriculomegaly, characteristic of PHHP.

RESULTS
This model incorporates prenatal CNS injury from CAM, early
postnatal IVH with syngeneic lysed RBCs, and neurological
assessment for 3 weeks through P21 in rodents, a period
with some CNS developmental equivalence in humans to early
childhood (Figure 1A). An initial cohort of 135 pups of
both sexes was used to characterize a model of PHHP [43
sham-veh (sterile saline) intraventricular injection, 35 sham-IVH,
27 CAM-veh, and 30 CAM-IVH]. Presence of IVH after injection
was confirmed by HUS in a subset of pups (Figure 1B). Early
mortality (<48 h) did not differ between injection groups,
and was 13% (18/135). No rats from the three control groups
(sham-veh, sham-IVH and CAM-veh) became symptomatic
from injections, while 4/24 (17%) of CAM-IVH rats that initially
survived required euthanasia prior to their targeted endpoint due
to progressive macrocephaly accompanied by lethargy and spastic
movements. Ventriculomegaly was confirmed on post-mortem
examination, and these animals were excluded from further
analyses. Surviving rats (113) were collected on P5, P15, and P21.

Cumulative Insults Precipitated
Developmental Delay
To assess neonatal neurodevelopment, a battery of
age-appropriate, validated, functional tests (Farkas et al.,
2009; Baharnoori et al., 2012) was administered. Most responses,
including somatic reflexes such as eye opening and startle
response, did not vary amongst the four groups (Supplementary
Figure S2). The forelimb placement reflex, the placement of
the forelimb on a shelf in response to stroking the dorsum
of the forelimb while the rat is suspended near the shelf,
was worse in CAM-veh and CAM-IVH rats compared to
sham-veh rats (Supplementary Figure S2G). Cliff aversion,
the time it takes a pup placed with its head and forelimbs
over a ledge to return to a safe position, was longer in injured
rats, consistent with early developmental delay. Specifically,
CAM-IVH rats (n = 24) exhibited longer cliff aversion times
compared to sham-veh rats (n = 24, p = 0.002), and sham-IVH
rats (n = 18, p < 0.001, Figure 1H). The CAM-veh rats (n = 31)
also showed impairment with cliff aversion, but did not differ
significantly from sham-veh or CAM-IVH rats. The pattern of
poor cliff aversion performance by CAM-IVH rats was more
pronounced in male rats than female rats (Supplementary
Figures S1E,F). Notably, cliff aversion performance correlated
with macrocephaly (r = 0.281, p = 0.040), and more robustly
with ventriculomegaly (r = 0.461, p < 0.001, Table 1), suggesting
that in this model early functional outcomes are associated with
macrocephaly and ventriculomegaly.

CAM-IVH Rats Exhibited Progressive
Macrocephaly and Ventriculomegaly
In human infants, symptomatic PHHP is characterized by
progressive macrocephaly with the head circumference crossing
percentiles for corrected-age. By P7, CAM-IVH pups developed
a dome-shaped cranium (Figure 1C). To track progressive
macrocephaly, intra-aural distance (IAD) was measured daily
as a surrogate for human head circumference. Beginning at
P5, a significant, progressive increase in IADs was observed in
CAM-IVH rats (n = 22) through P21, compared to sham-veh
(n = 33, mixed model repeated measures with Bonferroni’s
correction, p < 0.001), sham-IVH (n = 20, p < 0.001) and
CAM-veh rats (n = 19, p < 0.001) (Figure 1D). Both sexes
with CAM-IVH exhibited similar patterns of macrocephaly
(Supplementary Figures S1A,B). Thus, after the combination
of perinatal CAM-IVH, neonatal rats displayed progressive
macrocephaly through P21, a key component of PHHP.
To quantify early changes in ventricular size, P5 HE-stained
coronal sections were analyzed. Ventriculomegaly was observed
in CAM-IVH rats (n = 9), but not in sham-veh (n = 8, two-way
ANOVA with Bonferroni correction, p < 0.001) or sham-IVH
(n = 4, p = 0.003) rats (Figures 1E,F). Consistent with our
prior work (Jantzie et al., 2014a), CAM-veh rats (n = 5) showed
moderate ventricular enlargement compared to shams, but
smaller than CAM-IVH (all p > 0.05). Notably, the sham-IVH
and CAM-veh rats with mild ventriculomegaly did not exhibit
the progressive macrocephaly that was present only in CAM-IVH
rats. These results show prenatal CAM plus postnatal IVH causes
early ventriculomegaly.
To clarify whether the ventriculomegaly observed at P5 was
transient or sustained, ventricular volumes were analyzed at
P21 using ex vivo MRI. Ventricular volumes from CAM-IVH
rats (n = 8) were significantly larger than sham-veh (n = 5),
sham-IVH rats (n = 4), and CAM-veh rats (n = 6, Figure 1G).
Ventricular volume at P21 correlated with macrocephaly
(Pearson correlation r = 0.338, p = 0.012, Table 1). Together,
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Correlation of Phenotype With Early CNS
Insults
To estimate the relative contribution of early CNS insults to
phenotypic parameters important for PHHP, correlations were
tested between individual findings and types of CNS insults.
Macrocephaly (P21 IAD) correlated only with the combination
of CAM-IVH (r = 0.420, p = 0.010), and not with CAM or
IVH in isolation (Table 2). Similarly, ventriculomegaly correlated
only with CAM-IVH (r = 0.765, p = 0.002), and not with CAM
or IVH alone. Poor cliff aversion performance also correlated
with CAM-IVH (r = 0.467, p = 0.004, Table 2). Overall, only
the combined CAM-IVH correlated robustly with macrocephaly,
ventriculomegaly, and poor functional performance that are
characteristic of PHHP.

EPO+MLT Prevented Macrocephaly and
Neurodevelopmental Delay in PHHP-Like
Rats
To determine if the progressive macrocephaly and poor
cliff aversion performance observed in CAM-IVH rats was
preventable, we assessed the efficacy of combined EPO+MLT
treatment in the neonatal period in a separate cohort of rats
(n = 88). Specifically, on P2, CAM-IVH rats were randomized
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TABLE 1 | Pearson r correlation of phenotypic parameters with significant DTI scalars.
Parameter

Cliff aversion
Pearson r

p-value

Pearson r

p-value

0.281
X

p = 0.040

0.338
0.461

p = 0.012
p < 0.001

Macrocephaly (P21 IAD)
Cliff aversion
DTI scalars

Ventricular volume

Macrocephaly P21 IAD

Cliff aversion

Ventricular volume

Pearson r

p-value

Pearson r

p-value

Pearson r

p-value

White matter

FA

−0.585

p = 0.001

−0.447

p = 0.012

−0.376

p = 0.040

Corpus callosum

FA

−0.427

p = 0.015

−0.361

p = 0.006

−0.325

p = 0.070

Hippocampus

FA

−0.541

p = 0.001

−0.247

p = 0.181

−0.099

p = 0.591

Striatum

FA

−0.318

p = 0.076

−0.444

p = 0.012

−0.205

p = 0.261

Thalamus

FA

−0.201

p = 0.270

−0.320

p = 0.079

−0.210

p = 0.249

White matter

MD

0.422

p = 0.016

0.320

p = 0.079

0.291

p = 0.106

Corpus callosum

MD

0.467

p = 0.007

0.382

p = 0.034

0.383

p = 0.030

White matter

RD

0.435

p = 0.013

0.385

p = 0.033

0.619

p < 0.000

Corpus callosum

RD

0.552

p = 0.001

0.350

p = 0.006

0.445

p = 0.011

Bolded values indicate statistical significance.

TABLE 2 | Pearson r correlation of CNS insults with phenotypic parameters and significant DTI scalars.
Clinical parameter

Chorioamnionitis

Pearson r p-value

IVH

Chorioamnionitis
plus IVH
(vehicle)∗

Pearson r p-value

Pearson r p-value

Chorioamnionitis
plus IVH
(EPO+MLT)∗∗
Pearson r p-value

−0.103

p = 0.574

−0.192

p = 0.405

0.420

p = 0.010

−0.599

p < 0.001

Cliff aversion

0.323

p = 0.062

−0.462

p = 0.015

0.467

p = 0.004

−0.367

p = 0.042

Ventricular volume

0.522

p = 0.100

−0.028

p = 0.943

0.765

p = 0.002

−0.341

p = 0.056

DTI scalar

Chorioamnionitis

Macrocephaly (P21 IAM)

Pearson r p-value

IVH

Chorioamnionitis
plus IVH
(vehicle)∗

Pearson r p-value

Pearson r p-value

Chorioamnionitis
plus IVH
(EPO+MLT)∗∗
Pearson r p-value

White matter FA

−0.421

p = 0.197

−0.626

p = 0.071

−0.813

p = 0.002

0.800

p < 0.001

Corpus callosum FA

−0.532

p = 0.092

−0.374

p = 0.322

−0.791

p = 0.001

0.830

p < 0.001

Hippocampus FA

−0.266

p = 0.430

0.122

p = 0.773

−0.735

p = 0.004

0743

p = 0.001

Striatum FA

−0.411

p = 0.209

−0.663

p = 0.052

−0.641

p = 0.018

0.801

p < 0.001

Thalamus FA

p = 0.012

−0.637

p = 0.035

0.244

p = 0.527

−0.640

p = 0.019

0.896

White matter MD

0.261

p = 0.437

0.176

p = 0.651

0.792

p = 0.001

−0.260

p = 0.313

Corpus callosum MD

0.356

p = 0.282

0.046

p = 0.927

0.836

p < 0.001

−0.670

p = 0.003

White matter RD

0.391

p = 0.234

0.392

p = 0.296

0.874

p < 0.001

−0.347

p = 0.173

Corpus callosum RD

0.268

p = 0.425

0.036

p = 0.927

0.863

p < 0.001

−0.876

p < 0.001

Bolded values indicate statistical significance. ∗ Chorioamnionitis, IVH and CAM-IVH rat correlations compared with sham-veh rats.
compared with vehicle-treated CAM-IVH rats.

to an extended regimen of EPO+MLT or vehicle from P2 to
P10. To determine whether the combination of EPO+MLT
had any unanticipated impact on neurodevelopment, naïve rats
were randomized to the same EPO+MLT regimen (n = 20),
or vehicle (n = 10). No differences in neurodevelopment were
detected (Supplementary Figure S3), consistent with prior
studies showing no detrimental effects of EPO or MLT in
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∗∗ EPO+MLT-treated

CAM-IVH rats

shams (Mazur et al., 2010; Carloni et al., 2014, 2016). Thus,
shams received only vehicle for the remainder of the studies.
While vehicle-treated CAM-IVH rats exhibited a domed head,
EPO+MLT-treated CAM-IVH rats did not (Figure 2A). At P5,
the IADs of the EPO+MLT-treated CAM-IVH rats (n = 15) were
significantly lower than IADs of the vehicle-treated CAM-IVH
rats (n = 28, mixed model repeated measures with Bonferroni
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correction, p = 0.017, Figure 2B). By P21, the IADs of the
EPO+MLT-treated rats remained similar to shams (n = 28),
and were markedly less than the vehicle-treated CAM-IVH rats
(p < 0.001). By contrast, when EPO alone (n = 9), or MLT alone
(n = 5) were administered to CAM-IVH rats, the IADs were
not significantly different compared littermates that received
vehicle (n = 8, Supplementary Figure S1I). The EPO+MLT
treatment prevented progressive macrocephaly in both male
and female rats (Supplementary Figures S1C,D). In addition
to preventing macrocephaly, neonatal EPO+MLT treatment
also mitigated poor performance on cliff aversion after CAMIVH. Compared to vehicle-treated CAM-IVH rats (n = 24),
EPO+MLT-treated CAM-IVH rats (n = 17) exhibited shorter
cliff aversion times (p = 0.026), and performed similar to shams
(n = 24, Figure 2C). None of the other reflexes were significantly
impacted by EPO+MLT, although a trend for surface righting
was apparent (Supplementary Figure S2). While CAM-IVH
rats of both sexes showed a similar pattern of improved cliff
aversion performance with neonatal EPO+MLT treatment, the
differences were more prominent in males (Supplementary
Figures S1G,H). Thus, neonatal EPO+MLT treatment prevented
progressive macrocephaly and early signs of developmental delay
exhibited by vehicle-treated CAM-IVH rats.

EPO+MLT Treatment Improved
Ventriculomegaly in PHHP-Like Rats
To
determine
if
EPO+MLT
treatment
impacted
ventriculomegaly, we evaluated ventricular volume at P21.
Ventricular volume from ex vivo MRI was classified a priori
as normal (<10 mm3 ), mild (10–<15 mm3 ), moderate
(15–25 mm3 ) or severe (>25 mm3 ) ventriculomegaly
(Figure 2D). All of the sham-veh (5/5) and sham-IVH
(4/4) rats had normal ventricular volume. Two-thirds (4/6)
of CAM-veh rats exhibited a normal volume, while one-third
had mild or moderate ventriculomegaly without macrocephaly,
consistent with posthemorrhagic ventricular dilation observed
in some toddlers born preterm with CNS injury (Pappas et al.,
2018). All (9/9) of the vehicle-treated CAM-IVH rats showed
ventriculomegaly (33% mild, 22% moderate, and 44% severe).
By contrast, 44% (4/9) of EPO+MLT-treated rats had a normal
ventricular volume and only 11% had severe ventriculomegaly,
a significant reduction in the proportion with ventriculomegaly
compared to vehicle-treated CAM-IVH rats (Wilcoxon rank sum
test, p = 0.005). The reduction of ventriculomegaly combined
with the lack of macrocephaly suggests that PHHP occurs along
a spectrum of severity that can be modulated with a timely
neuroreparative intervention.

FIGURE 2 | Extended neonatal treatment with erythropoietin (EPO) plus melatonin (MLT) prevents progressive macrocephaly and neurodevelopmental delay, and
reduces sustained ventriculomegaly in CAM-IVH rats. (A) At P16, a vehicle-treated CAM-IVH rat exhibits a domed cranial vault, while the EPO+MLT-treated
CAM-IVH rat does not. (B) IADs of EPO+MLT-treated CAM-IVH rats diverge from those of vehicle-treated CAM-IVH rats, and become similar to sham-veh rats. (C)
EPO+MLT treatment of CAM-IVH rats prevents delayed performance on cliff aversion, compared to vehicle-treated CAM-IVH rats. (D) Ventricular volume measured
on MRI at P21 was defined as normal, and mild, moderate and severe ventriculomegaly. Sham-veh and sham-IVH rats all had normal size ventricles, while all
vehicle-treated CAM-IVH rats had ventriculomegaly. After neonatal EPO+MLT treatment, 40% of CAM-IVH rats had normal size ventricles, and the proportion with
more severe ventriculomegaly shifted to less severe. Importantly, none of the EPO+MLT CAM-IVH rats with residual ventriculomegaly had macrocephaly. (B: a mixed
model repeated measures ANOVA with Bonferroni’s correction; C: two-way ANOVA with Bonferroni’s correction; D: Wilcoxon rank sum test, ∗ p < 0.05, ∗∗ p ≤ 0.01,
∗∗∗ p ≤ 0.001.)
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CAM-IVH rats compared to shams in the hippocampus
(p = 0.022, Figure 4D), striatum (p = 0.028, Figure 4E)
and thalamus (p = 0.030, Figure 4F). Significantly, neonatal
EPO+MLT treatment in CAM-IVH rats prevented loss of gray
matter microstructural integrity in hippocampus (p < 0.001),
striatum (p < 0.001), and thalamus (p = 0.018). Thus, while
CAM-IVH causes extensive loss of microstructural integrity by
P21, neonatal EPO+MLT treatment prevents this widespread
damage.
To more specifically examine microstructural integrity in
the corpus callosum and ECWM, we assessed directional
diffusion. Mean diffusivity (MD) was elevated in the corpus
callosum of vehicle-treated CAM-IVH rats compared to shams
(p = 0.001) and EPO+MLT-treated CAM-IVH rats (p = 0.008,
Figures 5A,B). Axial diffusivity was not altered in the corpus
callosum of CAM-IVH rats (Figure 5C). By contrast, radial
diffusivity (RD), a potential imaging biomarker of myelin injury,
was also elevated in the corpus callosum of vehicle-treated
CAM-IVH rats, compared to shams and EPO+MLT-treated
CAM-IVH rats (both p < 0.001, Figure 5D). Similarly, ECWM
RD was elevated in vehicle-treated CAM-IVH rats, compared
to shams (p = 0.001) and EPO+MLT-treated CAM-IVH rats
(p = 0.027, Figure 5E). Together, these findings show that
the corpus callosum and ECWM are particularly vulnerable
to CAM-IVH, and that early EPO+MLT treatment can
prevent microstructural abnormalities caused by prenatal CAM
plus IVH.
We tested correlations of DTI scalars with macrocephaly,
impaired cliff aversion performance, and ventriculomegaly
(Table 1). Macrocephaly (P21 IAD) correlated robustly with
FA in the ECWM (p = 0.001), corpus callosum (p = 0.015)
and hippocampus (p = 0.001). Similarly, poor cliff aversion
performance correlated strongly with FA in the ECWM
(p = 0.012), corpus callosum (p = 0.006), and striatum
(p = 0.012), while ventriculomegaly correlated with corpus
callosum FA (p = 0.04). For mean diffusivity, all three phenotypic
metrics (macrocephaly, poor cliff aversion performance, and
ventriculomegaly) showed strong correlation with corpus
callosum MD (all p < 0.03, Table 1), while only macrocephaly
was associated with altered ECWM MD (p = 0.016). Moreover,
for radial diffusivity, all three phenotypic metrics showed strong
correlation with both corpus callosum and ECWM RD (all
p < 0.035, Table 1). Together, these finding show DTI scalars,
particularly RD of white matter, are indicative of phenotypic
parameters that most closely resemble PHHP, and suggest that
metrics of directional diffusion may serve as biomarkers of
PHHP severity and recovery.
Next, to test the impact of different components of CNS
injury on DTI scalars, we examined the correlations between
CAM, IVH, and CAM-IVH compared to shams. Only thalamic
FA correlated with CAM alone (p = 0.035), and only striatal
FA showed a trend with IVH alone (p = 0.052, Table 2).
By contrast, FA from both white and gray matter correlated
with CAM-IVH (all p < 0.02). Moreover, for both ECWM
and corpus callosum, both MD and RD showed very robust
correlations with CAM-IVH (all p ≤ 0.001). Finally, the
correlations between DTI scalars for vehicle-treated compared

FIGURE 3 | Coronal T2 images demonstrate ventricular size. Directionally
encoded color maps of coronal images reveal widespread white and gray
matter microstructural abnormalities in vehicle-treated CAM-IVH rats that are
prevented by neonatal EPO+MLT treatment. Color maps show loss of
microstructural coherence and impaired directional diffusion in regions with
poor microstructural integrity. Directional colors are red for transverse, green
for vertical and blue for orthogonal to the plane.

Microstructural Abnormalities Improved
With EPO+MLT Treatment
Due to the challenges in obtaining reliable functional outcomes
in neonates, DTI has emerged as an imaging biomarker for
perinatal brain injury (Vollmer et al., 2017; Hollund et al.,
2018; Olsen et al., 2018). In particular, congenital hydrocephalus
in children is associated with widespread DTI microstructural
abnormalities (Mangano et al., 2016; Zhao et al., 2016). To
supplement the functional outcome quantified with the behavior
battery, we assessed regional variation in white and gray matter
microstructure (Figures 3, 4A). Vehicle-treated CAM-IVH rats
(n = 8) had markedly lower external capsule white matter
(ECWM) fractional anisotropy (FA) at P21 compared to shams
(n = 5, two-way ANOVA with Bonferroni’s correction p < 0.001),
that improved with EPO+MLT (n = 9, p = 0.001, Figure 4B)
A similar pattern with FA was observed in the central corpus
callosum (shams versus vehicle-treated CAM-IVH, p = 0.002;
vehicle-treated versus EPO+MLT-treated CAM-IVH, p < 0.001,
Figure 4C). Likewise, gray matter FA was lower in vehicle-treated
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FIGURE 4 | Diffusion tensor imaging (DTI) regional analyses and fractional anisotropy (FA) graphs quantify prevention of loss of microstructural integrity. (A) Diagram
of DTI regions of interest (purple – striatum, yellow – corpus callosum, pink – external capsule white matter (ECWM), green – thalamus, and maroon – hippocampus).
(B) Reduction of FA in the ECWM of vehicle-treated CAM-IVH rats is prevented in CAM-IVH rats with neonatal EPO+MLT treatment. (C) Similarly, reduction of FA in
the central corpus callosum of vehicle-treated CAM-IVH rats is prevented by EPO+MLT treatment. (D) FA in the hippocampus is also decreased in vehicle-treated
CAM-IVH rats compared to shams, and EPO+MLT treatment mitigates the damage. (E) Likewise, FA in the striatum is reduced in vehicle-treated CAM-IVH rats, and
prevented in EPO+MLT-treated CAM-IVH rats. (F) FA in the thalamus is also lower in vehicle-treated CAM-IVH rats compared to shams, and normalizes with
EPO+MLT treatment (all comparisons are two-way ANOVA with Bonferroni’s correction, ∗ p < 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001).

to EPO+MLT-treated CAM-IVH rats were analyzed. These also
showed strong correlations with DTI scalars when compared with
vehicle-treated CAM-IVH rats (Table 2). Thus, in addition to
DTI correlating with phenotypic parameters, DTI scalars may
hold promise as imaging biomarkers for specific CNS insults
associated with PHHP, and neurorepair.

of cilia from vehicle-treated CAM-IVH rats were missing, while
the remaining cilia were matted, flattened, and lacked the tuft-like
appearance found in shams. Importantly, EPO+MLT treatment
prevented the damage and restored the tuft-like appearance of
EMC in CAM-IVH rats. Thus, these results demonstrate neonatal
EPO+MLT treatment can modulate structural damage to EMC
after CAM-IVH.

EPO+MLT Treatment Ameliorated
Morphological Damage to Ependymal
Motile Cilia

EPO+MLT Prevented Low
Yes-Associated Protein (YAP) mRNA
Levels at P15

To examine EMC morphology, scanning electron microscopy
(SEM) was performed on anatomically matched micro-dissected
portions of the lateral ventricular wall on P21. Cilia from sham
rats appeared in organized tufts (Figure 6). By contrast, a subset
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FIGURE 5 | Directional diffusivity in central corpus callosum and external capsule white matter is altered by CAM-IVH and EPO+MLT treatment. (A) Mean diffusivity
is elevated in the corpus callosum vehicle-treated CAM-IVH rats, compared to shams and EPO+MLT-treated CAM-IVH rats. (B) Ellipsoids comprised of the three
major eigenvectors of diffusion in the central corpus callosum illustrate the changes in vehicle-treated and EPO+MLT-treated CAM-IVH rats. (C) Axial diffusivity is
relatively unaffected by CAM-IVH. (D) Vehicle-treated CAM-IVH rats exhibit elevated radial diffusivity (RD) in central corpus callosum, and neonatal EPO+MLT
treatment normalizes the microstructural integrity. (E) Similarly, vehicle-treated CAM-IVH rats show increased RD in the ECWM, and neonatal EPO+MLT treatment
normalizes the RD (all comparisons are two-way ANOVA with Bonferroni’s correction, ∗ p < 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001).

P15. Reduction of YAP mRNA levels occurred in vehicletreated CAM-IVH rats (n = 4), compared to shams (n = 7,
p ≤ 0.001, Figure 7A). Neonatal EPO+MLT treatment following
CAM-IVH (n = 5) mitigated loss of YAP mRNA, compared to
vehicle treated CAM-IVH (two-way ANOVA with Bonferroni
correction, p = 0.036). These results provide initial support for
our hypothesis that CAM-IVH reduces YAP transcription, and
that EPO+MLT treatment prevents loss of YAP mRNA.

CAM-IVH rats with severe ventriculomegaly exhibited dense
GFAP+ expression, consistent with ventricular disruption
observed in human infants with IVH (McAllister et al., 2017).
GFAP-immunolabeling was moderate in EPO+MLT-treated
CAM-IVH rats with residual mild ventriculomegaly, while
EPO+MLT-treated rats with normal ventricular size had
minimal GFAP-immunolabeling, similar to shams. Notably,
in this age-appropriate CAM-IVH model, the degree of GFAP
expression appeared to vary inversely with ventriculomegaly.

EPO+MLT Treatment Reduced Excess
Ependymal GFAP Expression

DISCUSSION

To determine whether CAM-IVH substantially altered
periventricular gliosis, P21 coronal sections were immunolabeled
with GFAP (glial fibrillary acidic protein) antibodies. In the
lateral ventricle, GFAP-immunolabeling in vehicle-treated
CAM-IVH rats differed from shams, and demonstrated changes
in both the ependyma and choroid plexus (Figure 7B). After
EPO+MLT treatment, the ependyma showed less GFAP+
reactivity, and the choroid plexus resembled the choroid plexus
of shams. Ependymal changes were more dramatic in the third
ventricle (Figure 7C), consistent with a diffuse ependymal
reaction after CAM-IVH. Sham rats showed no enlargement of
the third ventricle, and minimal GFAP+ cells in the ependymal
lining (Figure 7C). By contrast, ependyma in vehicle-treated

We developed a clinically relevant model of PHHP that exhibits
essential components of PHHP, progressive macrocephaly
with ventriculomegaly, and used this model to test whether
extended EPO+MLT treatment can prevent the development
of PHHP. We found that EPO+MLT prevented progressive
macrocephaly and impaired cliff aversion performance, and
reduced ventriculomegaly. Neonatal EPO+MLT treatment
also normalized damage from CAM-IVH to microstructural
integrity of white and gray matter, ultrastructural injury
to EMC, periventricular YAP levels, and ependymal
GFAP-immunolabeling. These data indicate that the combination
of inflammation from prenatal CAM plus early postnatal IVH
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FIGURE 6 | Scanning electron microscopy (SEM) images of P21 ependymal motile cilia show preservation of cilia following EPO+MLT treatment in CAM-IVH rats.
(A) Low magnification images demonstrate a sheet of tuft-like morphology in sham-veh rats that is disrupted in vehicle-treated CAM-IVH rats. CAM-IVH rats with
EPO+MLT treatment exhibit preservation of the sheet of tufts of motile cilia. Bar = 10 microns. (B) Higher magnification images reveal some motile cilia in
vehicle-treated CAM-IVH rats are missing. Bar = 10 microns. (C) High magnification images show the residual cilia appear bloated and matted in vehicle-treated rats,
unlike the thinner, more upright cilia organized in tufts in sham-veh rats or EPO+MLT-treated CAM-IVH rats. Bar = 2 microns.

of PHHP, accompanied by histological, functional and imaging
findings consistent with those observed in preterm infants with
PHHP. EMC in CAM-IVH rats exhibited damage, similar to
damaged EMC observed after intracerebral hematoma and TBI
in the mature CNS (Xiong et al., 2014; Chen et al., 2015). The
combination of macrocephaly with ventriculomegaly reported
here is also similar to the morphology of models of symptomatic
hydrocephalus resulting from genetic mutations that impede
EMC development and/or function (Banizs et al., 2005; Tissir
et al., 2010; Yung et al., 2011; Peng et al., 2013; Vidovic et al.,
2015; Park et al., 2016; Muniz-Talavera and Schmidt, 2017;
Nunez-Olle et al., 2017; Takagishi et al., 2017; Abdelhamed et al.,
2018; Xu et al., 2018). Together, the unique combination of CAM
plus IVH, along with the age-appropriate timing of both insults,
increases the clinical relevance of this novel model.
We used this PHHP model to test whether systemic, extended
high-dose neonatal treatment with EPO+MLT could promote
recovery and prevent hydrocephalus. PHHP results from a
complex pattern of cumulative insults over the perinatal period,
and extended dosing with EPO+MLT likely normalizes the

damages EMC, likely limiting propulsion of CSF and leading
to symptomatic PHHP. The well-characterized prenatal injury
model of CAM used here causes pathological and functional
changes that mimic consequences of CNS injury from extremely
preterm birth (Jantzie et al., 2014a, 2018; Maxwell et al., 2015). In
juvenile rats, prenatal CAM produces a gait deficit reminiscent
of the spastic gait of cerebral palsy (Jantzie et al., 2014a), and
impaired executive function, social interaction and hyperactivity
(Jantzie et al., 2018). Importantly, because of the staggered timing
of CNS development and birth in rats compared to humans
[birth in Sprague-Dawley rats is equivalent approximately to 30
weeks gestation in humans, and P7-P10 in the rat is equivalent
to a term human (Semple et al., 2013; Jantzie and Robinson,
2015)], newborn rats mimic early preterm neonates and allow
age-appropriate testing of interventions. This novel model of
PHHP mimics the prenatal impact of CAM and intrauterine
inflammation on CNS maturation, plus replicates the timing
of IVH in early preterm infants by injecting lysed RBCs on
P1. Pups exposed to prenatal CAM-IVH developed persistent
ventriculomegaly with progressive macrocephaly, two hallmarks
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FIGURE 7 | Neonatal EPO+MLT treatment in CAM-IVH rats improves periventricular yes-associated protein (YAP) mRNA levels and reduces GFAP-expression.
(A) At P15, periventricular YAP mRNA levels are reduced in micro-dissected ependyma from vehicle-treated CAM-IVH rats, compared to shams. This loss is partially,
but significantly, prevented in CAM-IVH rats following EPO+MLT treatment. (B) GFAP-immunolabeling of coronal sections of the lateral ventricle show the choroid
plexus appears shrunken in the large ventricle. EPO-MLT-treatment prevents this appearance of the choroid plexus. (C) Minimal GFAP-immunolabeling is present in
the normal caliber third ventricle of a sham rat, while marked GFAP expression is present in the ependymal lining of the dilated third ventricle in a vehicle-treated
CAM-IVH rat. In an EPO+MLT-treated CAM-IVH rat with mild ventriculomegaly, there is less GFAP present, and this pattern is more apparent in the
EPO+MLT-treated CAM-IVH rat with a normal sized third ventricle (Bars = 100 microns, two-way ANOVA with Bonferroni’s correction, ∗ p < 0.05, ∗∗∗ p ≤ 0.001).

microenvironment and enhances recovery over a sustained
critical neurodevelopmental window. Preterm infants have
different clinical risks of CNS damage, arising from varying
patterns of IVH distribution and severity, plus other forms
of neonatal injury such as periventricular leukomalacia and
sepsis, and the genetic predisposition that impacts the response
to these cumulative insults. The extended dosing period and
combinatorial therapies likely addresses the varying severity,
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timing and individual predisposition to damage better than using
a single agent over the developmental window. Also, CAM
and IVH both affect multiple cell types in widespread CNS
regions, a complex amalgam that has been identified in other
forms of CNS injury from preterm birth (Volpe, 2009). This
diffuse, complex, cumulative pattern of injury sustained over
several weeks by preterm infants differs substantially from a
regionally and temporally specific injury such as a single occlusive
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mitigation of EMC damage, as observed with SEM in this
report.
Studies using DTI in children with hydrocephalus have
shown alterations in white matter microstructural integrity
(Mangano et al., 2016; Zhao et al., 2016), similar to what
we have shown here in toddler-equivalent P21 vehicle-treated
CAM-IVH rats. In preclinical studies, extended neonatal EPO
treatment mitigated widespread DTI abnormalities in white and
gray matter (Robinson et al., 2016, 2017). Here, we showed
that sustained neonatal treatment with EPO+MLT normalizes
subacute DTI changes at 3 weeks after CAM-IVH. To our
knowledge, this is the first report of the prevention of DTI
microstructural damage in a preclinical model of PHHP. Aojula
et al. (2016) used the transforming growth factors-β antagonist
decorin to prevent DTI changes at 2 weeks in a kaolin model
of hydrocephalus. Similarly, neonatal kaolin resulted in DTI
abnormalities at 5 and 10 days (Yuan et al., 2010). The DTI
analyses here demonstrated that both white matter and gray
matter, and particularly the corpus callosum, are sensitive to
CAM-IVH. While a component of white matter vulnerability
may be related to direct structural injury from ventriculomegaly,
it is likely that myelination and EMC function are precise, highly
regulated, relatively vulnerable processes with demanding energy
expenditures and environmental requirements. We reasoned that
the precise regulation of EMC maturation and function, as well as
recovery of more widespread injury to white and gray matter after
CAM-IVH, required a potent, multipronged intervention. This
led us to test a neonatal, sustained, high-dose, neuroprotective,
clinically relevant dosing regimen of EPO+MLT.
While clinical studies have shown that isolated neonatal
symptomatic hydrocephalus does not cause chronic neurological
deficits (Radic et al., 2015), children with PHHP often
suffer from additional neurological co-morbidities such as
cerebral palsy, behavioral abnormalities and impaired cognition.
Prenatal inflammation plus postnatal inflammation increases
the risk of white matter injury and spastic cerebral palsy
(Yanni et al., 2017), and many preterm infants with IVH
suffer from neonatal inflammation that likely contributes
to their poor functional outcomes. A sustained EPO+MLT
regimen, similar to the one used here, prevents chronic
motor, social, behavioral and cognitive deficits in adult rats
following prenatal CAM (Jantzie et al., 2018). In this study
EPO+MLT treatment prevented poor performance on cliff
aversion, however, tests of neonatal function in rodents are
inherently limited. Using a strategy similar to EPO+MLT
to induce multi-faceted repair, intravenous or intraventricular
injection of umbilical-cord derived mesenchymal stromal cells
on P6 improved early functional outcomes and reduced
ventriculomegaly and GFAP-expression in rats with IVH on
P4 or P5 (Ahn et al., 2013; Mukai et al., 2017). Repetitive
dosing with EPO+MLT has the distinct advantages of providing
sustained stabilization of the microenvironment over extended
perinatal course, known safety profile, ease of administration,
and cost. Early intervention for ventriculomegaly from IVH may
improve long term cognition in very selected populations (Leijser
et al., 2018), yet preterm infants with two or more surgeries
as neonates have lower cognitive scores (Gano et al., 2015),

middle cerebral artery stroke. EPO and MLT also have numerous
overlapping complementary mechanisms of action on neural
cells that result in repair (Brines et al., 2000; Carloni et al.,
2008). Receptors for both EPO and MLT are present on neural
cells (Mazur et al., 2010; Bahna and Niles, 2017; Ng et al.,
2017; Osier et al., 2017; Tsai et al., 2017), and both EPO and
MLT enhance the genesis, survival and maturation of multiple
neural cell types (Iwai et al., 2010; Mazur et al., 2010; Jantzie
et al., 2013; Li et al., 2017; Zhang et al., 2018). EPO and MLT
reduce neuroinflammation and oxidative stress (Carloni et al.,
2016; Ramirez-Jirano et al., 2016; Dominguez Rubio et al., 2017;
McDougall et al., 2017; Wang et al., 2017; Wei et al., 2017; Zhou
et al., 2017). They also restore the microenvironment by limiting
excess calpain activity that promotes cell death and destroys
molecules essential for neurodevelopment (Samantaray et al.,
2008; Jantzie et al., 2014b, 2016; Robinson et al., 2016). EPO
and MLT reduce endoplasmic reticulum stress and mitochondrial
dysfunction that may propagate chronic damage and precipitate
early neurodegeneration (Hong et al., 2012; Das et al., 2013;
Carloni et al., 2014; Fernandez et al., 2015; Hadj Ayed Tka
et al., 2015; Zhao et al., 2015; Hu et al., 2016; Hardeland,
2017; Mendivil-Perez et al., 2017; Xue et al., 2017). Additionally,
EPO+MLT treatment likely suppresses LPA, increases YAP, and
enhances ependymal renewal, which when combined with white
matter repair, provides a unique advantage to stimulate recovery
from the cascade of insults the cumulatively lead to PHHP.
Further work to delineate the specific mechanisms of how EPO
and MLT act together to optimize EMC maturation following
CAM-IVH are underway.
Systemic inflammation, particularly from maternal causes, is
associated with a higher risk of IVH (Moscuzza et al., 2011;
Salas et al., 2013; Arayici et al., 2014; Shankaran et al., 2014; Lee
et al., 2016; Lu et al., 2016; Stark et al., 2016; Chevallier et al.,
2017; Edwards et al., 2018). The Gram-negative endotoxin LPS
used here binds TLR4 (toll-like receptor 4), a receptor implicated
in neonatal parenchymal microhemorrhages (Carusillo Theriault
et al., 2017). Others have also shown that a TLR4 antagonist
limits damage from intracerebral hemorrhage (Wang et al., 2013;
Kwon et al., 2015). Systemic inflammation mediated via TLR4
increases choroid plexus CSF secretion (Karimy et al., 2017),
and likely contributes to ventriculomegaly in hydrocephalus. We
found that EPO+MLT treatment not only limited ependymal
GFAP-expression, but also prevented altered morphology of the
choroid plexus. Thus, there are multiple potential mechanisms to
explain why this combinatorial therapy limits the development of
PHHP.
We used this novel PHHP model to test the potential
reversibility of ependymal injury. Based on prior work (Yung
et al., 2011; Huang et al., 2016; Park et al., 2016), we
reasoned that one potential explanation connecting systemic
inflammation to the propensity to develop PHHP after IVH is
that systemic inflammation from LPS impacts ependymal cells,
and potentially neural cell progenitor differentiation, through
alterations in periventricular YAP mRNA levels. Here we report
that CAM-IVH reduces YAP transcription in micro-dissected
ependyma, and that neonatal EPO+MLT prevents loss of YAP
mRNA. These data are consistent with a role for YAP in the
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sexes develop progressive macrocephaly, the study was not
sufficiently powered to determine how well each sex responds to
EPO+MLT treatment. Despite these and other limitations, this
novel model of PHHP and our initial findings using the clinically
viable EPO+MLT treatment to prevent macrocephaly with
ventriculomegaly, poor cliff aversion performance and associated
microstructural abnormalities warrants additional investigation.

and shunt surgery at a young age increases the risk of shunt
malfunction (Riva-Cambrin et al., 2016). While the timing of
interventions for sick preterm infants with PHHP is a complex
and evolving controversy, non-surgical intervention such as
neonatal EPO+MLT could potentially minimize the need for
more invasive procedures and their associated risks.
The pathogenesis of PHHP is likely similar to other types
of acquired hydrocephalus from TBI, adult IVH, subarachnoid
hemorrhage, or meningitis. The association between CNS
inflammation and hydrocephalus is well known (Del Bigio and
Di Curzio, 2016). More recently the association with systemic
inflammation has been found. Sepsis increases the risk of
developing hydrocephalus in infants and young children with
TBI (Rumalla et al., 2018). Similarly, Wessell et al. (2018) showed
that sustained systemic inflammatory response syndrome (SIRS)
increases the risk of developing shunt-dependent hydrocephalus
after aneurysmal subarachnoid hemorrhage. Adults with severe
TBI are more likely to need surgical treatment for hydrocephalus
in the presence of ventriculitis/meningitis (Bauer et al., 2011;
Hu et al., 2018). Interestingly, after adult stroke in a preclinical
model, increased GFAP expression was found in the ependymal
lining, and EMC were affected, but hydrocephalus did not
develop (Young et al., 2013). Numerous differences in the
manifestations of injury and potential for repair exist between
the developing and mature CNS. Current preclinical experiments
are underway to determine whether findings from this study are
relevant to acquired hydrocephalus in adults.
This study has several limitations. Many important
mechanistic questions are beyond the scope of this initial
report. Additional experiments are needed to clarify the limits on
the timing and extent of renewal of ependymal cells and EMC,
and thus the duration of the optimal dosing regimen. While
the results presented here support our hypothesis that EMC
damage in the neonatal period can be modulated significantly
by endogenous neuroprotective agents, the situation in human
neonates with PHHP is likely more complex. More specifically
targeted therapies may add benefit, particularly in vulnerable
patients due to their genetic or epigenetic risk factors. Still, the
findings presented here suggest that neonatal EPO+MLT may
offer a safe, effective, cost-sensitive treatment for at least a subset
of infants with PHHP. Additional studies are underway to test
cognitive outcomes in young adult rats after CAM-IVH. This
is exceedingly important as children with ventricular dilatation
after IVH of prematurity have cognitive deficits (Holwerda
et al., 2016), and those who require surgical intervention are at
even higher risk for poor outcomes (Adams-Chapman et al.,
2008; Holwerda et al., 2016). Elevated LPA levels from systemic
inflammation may reduce YAP transcription and its specification
of radial glial cells to differentiate into ependymal cells, however,
investigation of this hypothesis requires additional studies
to clarify the timing of damage, and therapeutic window for
repair. Our initial findings suggest that ventriculomegaly in this
model is associated with diffuse ependymal GFAP+ reaction,
however, any potential causal relationship is currently unknown.
Experiments to evaluate the long term impact of CAM-IVH
and the association with macrocephaly and ventriculomegaly
are underway. Moreover, while we demonstrated that both
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CONCLUSION
In conclusion, early preterm birth and its associated
complications, including IVH and PHHP, remain a serious global
challenge to infant and childhood mortality and morbidity. The
findings reported here address several of the needs identified
in a recent NIH-sponsored symposium on hydrocephalus
(McAllister et al., 2015). The age-appropriate, clinically relevant
model of PHHP induced by prenatal CAM plus P1 IVH provides
a means to test mechanisms and potential interventions to
modulate hydrocephalus in neonates. Our results support the
use of DTI as an imaging biomarker of injury and repair for
PHHP. Most importantly, use of a clinically viable regimen of
endogenous neuroprotective agents EPO and MLT to prevent
PHHP suggests that safe, economically sound, non-surgical
treatments for hydrocephalus may be possible to transform the
care of preterm infants with severe IVH in the near future.
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trend for female vehicle-treated CAM-IVH rats (n = 10) compared to sham-veh
(n = 12) and EPO+MLT-treated CAM-IVH rats (n = 9) is similar to the male rats, the
differences are not statistically significant. (I) To test the efficacy of EPO alone or
MLT alone, CAM-IVH littermates were treated with vehicle (n = 8), EPO alone
(n = 9), MLT alone (n = 5), or EPO+MLT (n = 8), and compared to vehicle-treated
CAM-veh rats (n = 13). P21 IADs of EPO-treated or MLT-treated CAM-IVH rats
were not different than vehicle-treated CAM-IVH rats. By contrast, IADs of
EPO+MLT-treated CAM-IVH rats were different than vehicle-treated CAM-IVH
rats, and were similar to the CAM-veh controls. (Comparisons are A–D: a mixed
model repeated measures ANOVA; E–I: two-way ANOVA with Bonferroni’s
correction, ∗ p < 0.05, ∗∗ p ≤ 0.01, ∗∗∗ p ≤ 0.001.)

SUPPLEMENTARY MATERIAL

FIGURE S2 | Neurobehavioral tests in neonatal rats are minimally affected by
CAM-IVH. (A) Surface righting, the sum of the time to turn from lying on the back
to upright on feet during three trials from P7 to P9, was mildly impaired in
CAM-IVH rats compared to sham-veh rats, but the difference was not significant.
The negative geotaxis (B, sum of time to redirect when placed on an inclined
plane from pointing head down, with maximum of 30 s), the presence of forelimb
grasp on P8 (C), the presence of audio startle on P13 (D), the presence of eye
opening on P14 (E), and the presence of ear twitch to cotton wisp on P14 (F) all
did not differ between groups. (G) The presence of forelimb placement to stimulus
on the dorsum of the forelimb on P15 was reduced in injured rats. (H) The ability
to turn upright after being dropped upside down above a cushioned surface on
P12 did not differ between groups. (I) Surface righting improved mildly in
EPO+MLT-treated CAM-IVH rats compared to vehicle-treated CAM = IVH rats,
but the trend was not significant. (J–P) None of the other reflexes differed
significantly between the vehicle and EPO+MLT-treated CAM-IVH rats [n = 16–31,
two-way ANOVA with Bonferroni correction (A,B,I,J) or Kruskal–Wallis with Dunn’s
post hoc correction (C–H,K–P)]. ∗ p < 0.05, ∗∗∗ p < 0.001.

The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fncel.
2018.00322/full#supplementary-material
FIGURE S1 | Both male and female rats exhibit similar patterns of progressive
macrocephaly and poor cliff performance after CAM-IVH, and respond similarly to
EPO+MLT treatment. (A) Male CAM-IVH rats (n = 10) show significant
macrocephaly from P10 through P21, compared to sham-veh (n = 17), sham-IVH
(n = 9), and CAM-veh (n = 10) rats. (B) Similarly, female CAM-IVH rats (n = 12)
have larger IADs compared to sham-veh (n = 16), sham-IVH (n = 11), and
CAM-veh rats (n = 9). (C) Neonatal EPO+MLT treatment prevents progressive
macrocephaly in male CAM-IVH rats (n = 9), compared to vehicle-treated
CAM-IVH rats (n = 13). By P21, IADs of male EPO+MLT-treated rats are similar to
male shams (n = 15). (D) Similarly, the IADs of female EPO+MLT-treated rats
(n = 6) match female shams (n = 13), and diverge from female vehicle-treated
CAM-IVH rats (n = 15). (E) For cliff aversion, male CAM-IVH rats (n = 14) perform
worse than sham-veh rats (n = 12) and sham-IVH rats (n = 8), while CAM-veh rats
(n = 17) also perform poorly. (F) Female CAM-veh (n = 10) and CAM-IVH rats
(n = 14) show a similar pattern, compared to sham-veh (n = 12) and sham-IVH
(n = 10) rats, but the differences are not statistically significant. (G) Male
vehicle-treated CAM-IVH rats (n = 14) perform poorly on cliff aversion compared to
sham-veh rats (n = 12) and EPO+MLT–treated CAM-IVH rats (n = 8). (H) While the

FIGURE S3 | Neurodevelopment was assessed in naïve rats treated with
EPO+MLT (n = 20) or vehicle (n = 10). Surface righting on P5–P7 (A), negative
geotaxis on P8–P14 (B), cliff aversion on P12–P13 (C), forelimb grasp on
P10–P11 (D), ear twitch on P14 (E), forelimb placement on P15 (F), and air
righting on P12 (G) did not differ between vehicle-treated and EPO+MLT-treated
naïve rats.
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